It carries a safe status and simplifies the regulatory process for new product launches
the EMA and UK SmPC attribute this to weight loss rather than a direct drug effect
This dual approach, validated through extensive Mounjaro clinical trials, offers distinct advantages over single-pathway medications like semaglutide (Wegovy/Ozempic), liraglutide (Saxenda), and dulaglutide (Trulicity)
Additionally, 15 of the included studies focused on B12 supplementation, with a total of 5,191 participants (mean: 346 per study)
Understanding How Semaglutide Works for Weight Loss and Diabetes Semaglutide, the active ingredient in FDA-approved medications like Wegovy, Ozempic, and Rybelsus, is a GLP-1 receptor agonist